Skip to main content

TC BioPharm (Holdings) plc

TCBPDelisted Aug 8, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001872812

TC BioPharm (Holdings) plc was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Jan 11, 2023; 12 institutions reported holding it in 13F filings for Q3 2023, worth $179.6K in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
12
Q3 2023, +6 vs. previous quarter
13F value
$179.6K
Reported value at the end of Q3 2023
Superinvestors holding
0
At the end of Q3 2023

Superinvestors holding TCBP, Q3 2023

Go to the superinvestors tab

No superinvestor reported holding TCBP at the end of Q3 2023.

Latest insider trades

Open-market purchases and sales by TC BioPharm (Holdings) plc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRandall Diana Elizabeth10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0KNew position70.0K after
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRandall Diana Elizabeth10% OwnerPPurchase+140.0K$0.00$0–70.0K afterDerivative2 lotsDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Mark Edward10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0K+104.7%136.8K afterAmendedDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Mark Edward10% OwnerPPurchase+140.0K$0.00$0–70.0K afterAmendedDerivative2 lotsDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Kenneth Edward10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0K+104.7%136.8K afterAmendedDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysRandall Kenneth Edward10% OwnerPPurchase+140.0K$0.00$0–70.0K afterAmendedDerivative2 lotsDuplicate filing
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRenaissance Capital Partners Ltd10% OwnerPPurchaseOrdinary Shares [ADS]+70.0K$5.00+$350.0K+104.7%136.8K after
Jan 11, 2023 (view filing)Nov 30, 202242 daysLateRenaissance Capital Partners Ltd10% OwnerPPurchase+140.0K$0.00$0–70.0K afterDerivative2 lots
Jul 14, 2022 (view filing)May 2451 daysLateRandall Kenneth Edward10% OwnerPPurchaseOrdinary Shares [ADS]+20.8K$1.15+$23.9K+26.1%100.4K after

Top 10 13F holders, Q3 2023

The largest institutional positions in TC BioPharm (Holdings) plc at the end of Q3 2023; share changes are against Q2 2023.

See all 12 holders
Institutions holding TCBP in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC297,500$127.9K0.00%−230,813−43.7%Reduced
Csenge Advisory Group26,000$11.2K0.00%+26,000New
Cresset Asset Management, LLC25,000$10.8K0.00%+25,000New
Two Sigma Securities, LLC13,401$5.76K0.00%+13,401New
XTX Topco Ltd13,617$5.68K0.00%+13,617New
Citadel Advisors LLC13,543$5.65K0.00%−61,752−82.0%Reduced
Wells Fargo & Company13,000$5.59K0.00%00.0%Unchanged
Renaissance Technologies LLC11,003$5.00K0.00%−60,897−84.7%Reduced
UBS Group AG3,516$1.51K0.00%+416+13.4%Added
Clear Street LLC1,323$5690.00%+1,323New